Acquiring Company
Haemonetics
Acquired Company
OpSens
Boston
Quebec CityBiotechnologyHealth CareMedicalMedical DeviceMedical Equipment ManufacturingDescription
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has completed its previously announced acquisition of OpSens Inc., a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology.
Quick answer
Haemonetics is acquiring OpSens, announced December 12, 2023. Haemonetics is based in Boston, Massachusetts, United States.
- How much did Haemonetics pay for OpSens?
- The deal value was not disclosed.
- What does Haemonetics do?
- Haemonetics is a global healthcare company focused on providing innovative blood management solutions.
- Where are Haemonetics and OpSens based?
- Haemonetics is based in Boston, Massachusetts, United States. OpSens is based in Quebec City, Quebec, Canada.
- Who are the decision-makers at Haemonetics?
- Fundz holds 1 contact at Haemonetics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics (January 18, 2024)
- CardioFocus Acquires Electrophysiology Division of Galvanize Therapeutics (January 11, 2024)
- Nevro Announces Acquisition Of Vyrsa™ Technologies (November 30, 2023)
- Versiti Acquires Indianapolis-Based Pearl Pathways (November 7, 2023)
- Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio (January 23, 2024)
- Orthopediatrics Corp. Announces Acquisition Of Boston Orthotics & Prosthetics (January 8, 2024)
Who to call at Haemonetics, and when
When Haemonetics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Haemonetics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Haemonetics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Haemonetics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Haemonetics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired OpSens?
OpSens was acquired by Haemonetics, based in Boston. The deal was reported on December 12, 2023. Haemonetics is a global healthcare company focused on providing innovative blood management solutions. It specializes in blood donation, transfusion, and surgical procedures. Haemonetics is publicly traded (HAE) and operates in Biotechnology.
When did Haemonetics acquire OpSens?
Haemonetics's acquisition of OpSens was reported on December 12, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does OpSens do?
OpSens focuses mainly in interventional cardiology. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. It is privately held, operating in Medical Equipment Manufacturing, and is based in Quebec City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.